Support for Caregiver - Generic List
OtherReceive a generic resource list
NCT Number: NCT06383988
Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Kaiser Permanente-Franklin, Denver, Colorado, United States
This study is a multi-site randomized pilot trial enrolling 120 lung cancer caregiver-patient dyads (i.e., lung cancer caregivers (n=120) and their care-recipients (n=120)) across approximately 8-12 practices to assess the multi-site feasibility of a caregiver technology-based intervention (CONNECT) to identify caregivers' needs and connect them with supportive care resources. Caregivers will be randomized 1:1:1 to either the CONNECT intervention, usual care comparison group or generic resource list comparison group. CONNECT is a web-based intervention that empowers and educates caregivers about the benefits of supportive care services and systematically identifies unmet needs to connect lung cancer caregivers with tailored supportive care resources. The Central Caregiver Navigator will assist caregivers with resolving barriers to accessing resources and work with the Local Practice Referral Coordinator to process referrals. Caregivers and patients will complete measures at baseline (prior to caregiver randomization), and 12 and 24 weeks after baseline. Feasibility measures (retention, accrual rates, and participation) will be evaluated to inform the future trial. The Local Practice Referral Coordinator for each practice will report on time needed for practice participation, referral processes, and communication processes with the Central Caregiver Navigator.
Participants (i.e., patients or care-recipients) will be asked to complete study surveys at three time points:
Each survey will take about 30-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), cancer symptoms, satisfaction with cancer care and health behaviors. You don't have to answer any question that makes you feel uncomfortable. These surveys can be done remotely over the internet, in the clinic, by phone or by mail.
Caregivers will also complete surveys at three time points and will be assigned to 1 of 3 study groups:
Caregiver Participants (Group 1, 2 and 3) will be asked to complete study surveys at three time points:
Each survey will take about 35-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), caregiving experience, use of supportive care resources, quality of life, mood, and social needs (housing, transportation, utilities, etc). You don't have to answer any question that makes you feel uncomfortable.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Patient Inclusion Criteria:
Caregiver Inclusion Criteria:
Patient Exclusion Criteria:
Caregiver Exclusion Criteria:
Receive a generic resource list
Receive personalized resource list
Receive access to CONNECT tool
Complete calls with caregiver navigator
Other names: Patient Navigator Program
Time frame: At 12 weeks
Calculated as the following: Number of caregivers who complete at least 75% of the 12-week assessments divided by the number randomized. Retention will be estimated and reported along with an exact 95% confidence interval.
Time frame: Upon completion of recruitment, approximately 12 months
Number of caregivers who agree to participate divided by the number of months of recruitment
Time frame: Upon completion of recruitment, approximately 12 months
Proportion of eligible caregivers who agreed to participate
Time frame: At 24 weeks
Number of caregivers who complete at least 75% of the 24-week assessments divided by the number randomized.
Time frame: At 12 weeks
Self-report survey developed for this study to assess the degree to which caregivers found different aspects of CONNECT, the generic resource list, or usual care helpful using a Likert response from 0 (Not at all) to 5 (Very Much)
Time frame: At completion of training, up to 6 months
Will be summarized across practices using mean, median, standard deviation and interquartile range.
Time frame: At completion of training, up to 6 months
Will be summarized using appropriate descriptive statistics.
Time frame: At conclusion of practice intervention activities, an average of 18 months
Will be summarized across practices using mean, median, standard deviation and interquartile range.
Time frame: Up to completion of practice intervention activities, an average of 18 months
Will be summarized across practices using mean, median, standard deviation and interquartile range
Time frame: Up to completion of practice intervention activities, an average of 18 months
Will be summarized across practices using mean, median, standard deviation and interquartile range.
Time frame: Up to completion of practice intervention activities, an average of 18 months
Will be summarized using appropriate descriptive statistics.
Time frame: Up to completion of practice intervention activities, an average of 18 months
Will be summarized across practices using mean, median, standard deviation and interquartile range.
Time frame: Up to completion of practice intervention activities, an average of 18 months
Will be summarized across practices using mean, median, standard deviation and interquartile range.
Time frame: Up to completion of practice intervention activities, an average of 18 months
Will be summarized using appropriate descriptive statistics.
Time frame: Up to completion of practice intervention activities, an average of 18 months
Will be summarized across practices using mean, median, standard deviation and interquartile range.
Time frame: Up to completion of practice intervention activities, an average of 18 months
Will be summarized using appropriate descriptive statistics.
Time frame: At completion of practice intervention activities, an average of 18 months
Will be summarized using appropriate descriptive statistics.
Time frame: Upon completion of recruitment, approximately 12 months
Number of patients who agree to participate divided by the number of months of recruitment
Time frame: Upon completion of recruitment, approximately 12 months
Proportion of eligible patients who agreed to participate
Time frame: At 12 weeks
Number of patients who complete at least 75% of the 12-week assessments divided by the number randomized
Time frame: At 24 weeks
Number of patients who complete at least 75% of the 24-week assessments divided by the number randomized
Wake Forest University Health Sciences
Other
Multi-Site Community Oncology Planning for the CONNECT Intervention Targeting Lung Cancer Caregivers
Acronym: CONNECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05025748
Adnexal Diseases, Breast Diseases
Bay City, Michigan, United States
View Trial DetailsNCT05281237
Lung Cancer, Lung Cancer Stage I
Boston, Massachusetts, United States
View Trial DetailsNCT07412041
Bronchial Neoplasms, Carcinoma, Bronchogenic
View Trial DetailsNCT06593106
Lung Diseases, Lung Neoplasms
Nashville, Tennessee, United States
View Trial Details